909804-24-6

Basic information

• Product Name: (2-{[(2-tert-butoxycarbonylamino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid
• Synonyms: (2-{[(2-tert-butoxycarbonylamino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid
• CAS NO: 909804-24-6
• Molecular Weight: 308.185
• Mol File: 909804-24-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2-{[(2-tert-butoxycarbonylamino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2-{[(2-tert-butoxycarbonylamino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid(909804-24-6)
• EPA Substance Registry System: (2-{[(2-tert-butoxycarbonylamino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid(909804-24-6)

Safety Data

• Hazardous Substances Data: 909804-24-6(Hazardous Substances Data)

Upstream product

• 91983-14-1 2-bromomethylphenylboronic acid 
• 122734-32-1 tert-butyl 2-(methylamino)ethylcarbamate 

Downstream Products

• 909804-26-8 (2-{[(2-amino-ethyl)-methyl-amino]-methyl}-phenyl)-boronic acid 

Relevant articles and documents

COMPLEX COMPOUND AND MRI PROBE MADE OF SAME

Novel gadolinium complex compounds responsive to ions and compounds other than zinc ion, as well as MRI probes made of the compounds are disclosed. Since the gadolinium complex compounds of the present invention such as that represented by the following structural formula exhibit responsiveness to potassium ion, calcium ion, glucose or the like, by using the gadolinium complex compounds of the present invention as a MRI probe, the ion or compound in a living body can be detected and concentration distribution thereof may be determined.